ATLAS / Macro Radar / Reporting / SABS

SAB Biotherapeutics, Inc. (SABS) reporting calendar

SAB Biotherapeutics, Inc. files periodic reports with the SEC as SABS on Nasdaq. Atlas tracks 22 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
14 Jul 2026 – 4 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
22

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open SABS market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001193125-26-218195
10-K31 Dec 20259 Mar 202668 days0001833214-26-000003
10-Q30 Sep 202514 Nov 202545 days0001193125-25-280572
10-Q30 Jun 20257 Aug 202538 days0000950170-25-104566
10-Q31 Mar 20259 May 202539 days0000950170-25-067554
10-K31 Dec 202431 Mar 202590 days0000950170-25-046994
10-Q30 Sep 20246 Nov 202437 days0000950170-24-122443
10-Q30 Jun 20248 Aug 202439 days0000950170-24-094084
10-Q31 Mar 202420 May 202450 days0000950170-24-062367
10-K31 Dec 202329 Mar 202489 days0000950170-24-038219
10-Q30 Sep 202313 Nov 202344 days0000950170-23-063076
10-Q30 Jun 202321 Aug 202352 days0001437749-23-024224
10-Q31 Mar 202315 May 202345 days0001437749-23-014634
10-K31 Dec 202214 Apr 2023104 days0001437749-23-010343
10-Q30 Sep 202214 Nov 202245 days0000950170-22-025094
10-Q30 Jun 202210 Aug 202241 days0000950170-22-016221
10-Q31 Mar 202212 May 202242 days0000950170-22-009722
10-K31 Dec 202129 Mar 202288 days0000950170-22-004935
10-Q30 Sep 202122 Nov 202153 days0001493152-21-029551
10-Q30 Jun 20219 Aug 202140 days0001493152-21-019063
10-Q31 Mar 202121 May 202151 days0001493152-21-012524
10-K31 Dec 20202 Apr 202192 days0001493152-21-007884

Source: SEC EDGAR company submissions for CIK 0001833214. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.